Cargando…

Parkin is a disease modifier in the mutant SOD1 mouse model of ALS

Mutant Cu/Zn superoxide dismutase (SOD1) causes mitochondrial alterations that contribute to motor neuron demise in amyotrophic lateral sclerosis (ALS). When mitochondria are damaged, cells activate mitochondria quality control (MQC) mechanisms leading to mitophagy. Here, we show that in the spinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Palomo, Gloria M, Granatiero, Veronica, Kawamata, Hibiki, Konrad, Csaba, Kim, Michelle, Arreguin, Andrea J, Zhao, Dazhi, Milner, Teresa A, Manfredi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180298/
https://www.ncbi.nlm.nih.gov/pubmed/30126943
http://dx.doi.org/10.15252/emmm.201808888
_version_ 1783362173287792640
author Palomo, Gloria M
Granatiero, Veronica
Kawamata, Hibiki
Konrad, Csaba
Kim, Michelle
Arreguin, Andrea J
Zhao, Dazhi
Milner, Teresa A
Manfredi, Giovanni
author_facet Palomo, Gloria M
Granatiero, Veronica
Kawamata, Hibiki
Konrad, Csaba
Kim, Michelle
Arreguin, Andrea J
Zhao, Dazhi
Milner, Teresa A
Manfredi, Giovanni
author_sort Palomo, Gloria M
collection PubMed
description Mutant Cu/Zn superoxide dismutase (SOD1) causes mitochondrial alterations that contribute to motor neuron demise in amyotrophic lateral sclerosis (ALS). When mitochondria are damaged, cells activate mitochondria quality control (MQC) mechanisms leading to mitophagy. Here, we show that in the spinal cord of G93A mutant SOD1 transgenic mice (SOD1‐G93A mice), the autophagy receptor p62 is recruited to mitochondria and mitophagy is activated. Furthermore, the mitochondrial ubiquitin ligase Parkin and mitochondrial dynamics proteins, such as Miro1, and Mfn2, which are ubiquitinated by Parkin, and the mitochondrial biogenesis regulator PGC1α are depleted. Unexpectedly, Parkin genetic ablation delays disease progression and prolongs survival in SOD1‐G93A mice, as it slows down motor neuron loss and muscle denervation and attenuates the depletion of mitochondrial dynamics proteins and PGC1α. Our results indicate that Parkin is a disease modifier in ALS, because chronic Parkin‐mediated MQC activation depletes mitochondrial dynamics‐related proteins, inhibits mitochondrial biogenesis, and worsens mitochondrial dysfunction.
format Online
Article
Text
id pubmed-6180298
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61802982018-10-18 Parkin is a disease modifier in the mutant SOD1 mouse model of ALS Palomo, Gloria M Granatiero, Veronica Kawamata, Hibiki Konrad, Csaba Kim, Michelle Arreguin, Andrea J Zhao, Dazhi Milner, Teresa A Manfredi, Giovanni EMBO Mol Med Research Articles Mutant Cu/Zn superoxide dismutase (SOD1) causes mitochondrial alterations that contribute to motor neuron demise in amyotrophic lateral sclerosis (ALS). When mitochondria are damaged, cells activate mitochondria quality control (MQC) mechanisms leading to mitophagy. Here, we show that in the spinal cord of G93A mutant SOD1 transgenic mice (SOD1‐G93A mice), the autophagy receptor p62 is recruited to mitochondria and mitophagy is activated. Furthermore, the mitochondrial ubiquitin ligase Parkin and mitochondrial dynamics proteins, such as Miro1, and Mfn2, which are ubiquitinated by Parkin, and the mitochondrial biogenesis regulator PGC1α are depleted. Unexpectedly, Parkin genetic ablation delays disease progression and prolongs survival in SOD1‐G93A mice, as it slows down motor neuron loss and muscle denervation and attenuates the depletion of mitochondrial dynamics proteins and PGC1α. Our results indicate that Parkin is a disease modifier in ALS, because chronic Parkin‐mediated MQC activation depletes mitochondrial dynamics‐related proteins, inhibits mitochondrial biogenesis, and worsens mitochondrial dysfunction. John Wiley and Sons Inc. 2018-08-20 2018-10 /pmc/articles/PMC6180298/ /pubmed/30126943 http://dx.doi.org/10.15252/emmm.201808888 Text en © 2018 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Palomo, Gloria M
Granatiero, Veronica
Kawamata, Hibiki
Konrad, Csaba
Kim, Michelle
Arreguin, Andrea J
Zhao, Dazhi
Milner, Teresa A
Manfredi, Giovanni
Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
title Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
title_full Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
title_fullStr Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
title_full_unstemmed Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
title_short Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
title_sort parkin is a disease modifier in the mutant sod1 mouse model of als
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180298/
https://www.ncbi.nlm.nih.gov/pubmed/30126943
http://dx.doi.org/10.15252/emmm.201808888
work_keys_str_mv AT palomogloriam parkinisadiseasemodifierinthemutantsod1mousemodelofals
AT granatieroveronica parkinisadiseasemodifierinthemutantsod1mousemodelofals
AT kawamatahibiki parkinisadiseasemodifierinthemutantsod1mousemodelofals
AT konradcsaba parkinisadiseasemodifierinthemutantsod1mousemodelofals
AT kimmichelle parkinisadiseasemodifierinthemutantsod1mousemodelofals
AT arreguinandreaj parkinisadiseasemodifierinthemutantsod1mousemodelofals
AT zhaodazhi parkinisadiseasemodifierinthemutantsod1mousemodelofals
AT milnerteresaa parkinisadiseasemodifierinthemutantsod1mousemodelofals
AT manfredigiovanni parkinisadiseasemodifierinthemutantsod1mousemodelofals